Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.

Background: The Brazilian consensus recommends a short-term treatment course with clarithromycin, amoxicillin and proton-pump inhibitor for the eradication of Helicobacter pylori (H. pylori). This treatment course has good efficacy, but cannot be afforded by a large part of the population. Azithromy...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Gastroenterology Vol. 8; pp. 20 - 21
Autores principales: Silva FM, Eisig JN, Teixeira AC, Barbuti RC, Navarro-Rodriguez T, Mattar R, Silva, Fernando M, Eisig, Jaime N, Teixeira, Ana Cristina S, Barbuti, Ricardo C, Navarro-Rodriguez, Tomás, Mattar, Rejane
Formato: Journal Article
Publicado: BioMed Central 2008
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105218511&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 105218511
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        1471230X
        1CHO
      jtl: BMC Gastroenterology
      issn: 1471230X
      maglogo: N
    pubinfo:
      dt: 2008
      vid: 8
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        105218511
        NLM18510773
        2010133171
        10.1186/1471-230X-8-20
        NLM18510773
        105218511
      ppf: 20
      ppct: 1
      formats:
      tig:
        atl: Short-term triple therapy with azithromycin for Helicobacter pylori eradication: low cost, high compliance, but low efficacy.
      aug:
        au:
          Silva FM
          Eisig JN
          Teixeira AC
          Barbuti RC
          Navarro-Rodriguez T
          Mattar R
          Silva, Fernando M
          Eisig, Jaime N
          Teixeira, Ana Cristina S
          Barbuti, Ricardo C
          Navarro-Rodriguez, Tomás
          Mattar, Rejane
        affil: Serviço de Gastroenterologia Clínica, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Av, Dr, Enéas de Carvalho Aguiar, 155, 9 degree, Andar, Cerqueira Cezar, São Paulo, SP, CEP: 05 403-900, Brasil
      sug:
        subj:
          Azithromycin Administration and Dosage
          Azithromycin Economics
          Helicobacter Infections Drug Therapy
          Helicobacter Pylori Drug Effects
          Patient Compliance
          Peptic Ulcer Drug Therapy
          Adult
          Aged
          Aged, 80 and Over
          Amoxicillin Administration and Dosage
          Brazil
          Drug Administration Schedule
          Health Care Costs
          Drug Therapy, Combination
          Duodenal Ulcer Drug Therapy
          Duodenal Ulcer Microbiology
          Female
          Helicobacter Infections Microbiology
          Male
          Middle Age
          Omeprazole Administration and Dosage
          Peptic Ulcer Microbiology
          Treatment Outcomes
          Adult: 19-44 years
          Aged: 65+ years
          Aged, 80 & over
          Middle Aged: 45-64 years
          Female
          Male
      ab: Background: The Brazilian consensus recommends a short-term treatment course with clarithromycin, amoxicillin and proton-pump inhibitor for the eradication of Helicobacter pylori (H. pylori). This treatment course has good efficacy, but cannot be afforded by a large part of the population. Azithromycin, amoxicillin and omeprazole are subsidized, for several aims, by the Brazilian federal government. Therefore, a short-term treatment course that uses these drugs is a low-cost one, but its efficacy regarding the bacterium eradication is yet to be demonstrated. The study's purpose was to verify the efficacy of H. pylori eradication in infected patients who presented peptic ulcer disease, using the association of azithromycin, amoxicillin and omeprazole.Methods: Sixty patients with peptic ulcer diagnosed by upper digestive endoscopy and H. pylori infection documented by rapid urease test, histological analysis and urea breath test were treated for six days with a combination of azithromycin 500 mg and omeprazole 20 mg, in a single daily dose, associated with amoxicillin 500 mg 3 times a day. The eradication control was carried out 12 weeks after the treatment by means of the same diagnostic tests. The eradication rates were calculated with 95% confidence interval.Results: The eradication rate was 38% per intention to treat and 41% per protocol. Few adverse effects were observed and treatment compliance was high.Conclusion: Despite its low cost and high compliance, the low eradication rate does not allow the recommendation of the triple therapy with azithromycin as an adequate treatment for H. pylori infection.
      pubtype: Academic Journal
      doctype: Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N